Compare RERE & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RERE | CNMD |
|---|---|---|
| Founded | 2011 | 1970 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.3M | 1.0B |
| IPO Year | 2021 | 1995 |
| Metric | RERE | CNMD |
|---|---|---|
| Price | $3.91 | $32.39 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $46.25 |
| AVG Volume (30 Days) | ★ 1.2M | 459.2K |
| Earning Date | 05-19-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.27% | 1.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $1,374,724,000.00 |
| Revenue This Year | $25.70 | $0.82 |
| Revenue Next Year | $22.93 | $5.48 |
| P/E Ratio | $34.57 | ★ $21.25 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $2.76 | $31.84 |
| 52 Week High | $6.47 | $56.64 |
| Indicator | RERE | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.67 | 37.93 |
| Support Level | $3.69 | N/A |
| Resistance Level | $4.37 | $38.22 |
| Average True Range (ATR) | 0.18 | 1.63 |
| MACD | -0.03 | -0.23 |
| Stochastic Oscillator | 9.60 | 8.16 |
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platforms PJT Marketplace and Paipai Marketplace. The Company's principal operations and geographic markets are in the People's Republic of China.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.